| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACVR1C
|
activin A receptor, type IC
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGK
|
acylglycerol kinase
|
|
AGO1
|
argonaute RISC catalytic component 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIM2
|
absent in melanoma 2
|
|
AIRE
|
autoimmune regulator
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH16A1
|
aldehyde dehydrogenase 16 family, member A1
|
|
ALDH1B1
|
aldehyde dehydrogenase 1 family, member B1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALX3
|
ALX homeobox 3
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANO10
|
anoctamin 10
|
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AR
|
androgen receptor
|
|
ARG2
|
arginase 2
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARRB2
|
arrestin, beta 2
|
|
ARSA
|
arylsulfatase A
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN3
|
ataxin 3
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCAP31
|
B-cell receptor-associated protein 31
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BOLL
|
boule-like RNA-binding protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C7
|
complement component 7
|
|
C9
|
complement component 9
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CALD1
|
caldesmon 1
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD19
|
CD19 molecule
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD70
|
CD70 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDHR1
|
cadherin-related family member 1
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDSN
|
corneodesmosin
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHRFAM7A
|
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN1
|
claudin 1
|
|
CLDN7
|
claudin 7
|
|
CLPTM1L
|
CLPTM1-like
|
|
CMA1
|
chymase 1, mast cell
|
|
CMAHP
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COCH
|
cochlin
|
|
COIL
|
coilin
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS6
|
COP9 signalosome subunit 6
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2A2
|
casein kinase 2, alpha prime polypeptide
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTSL
|
cathepsin L
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CUX1
|
cut-like homeobox 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXXC1
|
CXXC finger protein 1
|
|
CXXC5
|
CXXC finger protein 5
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB4A
|
defensin, beta 4A
|
|
DGAT1
|
diacylglycerol O-acyltransferase 1
|
|
DGKD
|
diacylglycerol kinase, delta 130kDa
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DMD
|
dystrophin
|
|
DNM1L
|
dynamin 1-like
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DUSP12
|
dual specificity phosphatase 12
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECM1
|
extracellular matrix protein 1
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNB2
|
ephrin-B2
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR2
|
early growth response 2
|
|
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ENG
|
endoglin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
|
EPHA1
|
EPH receptor A1
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERO1LB
|
ERO1-like beta (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FADS2
|
fatty acid desaturase 2
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLG
|
filaggrin
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXA2
|
forkhead box A2
|
|
FOXO1
|
forkhead box O1
|
|
FOXP3
|
forkhead box P3
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
|
FSCN1P1
|
fascin actin-bundling protein 1 pseudogene 1
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GALNS
|
galactosamine (N-acetyl)-6-sulfatase
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GFRA3
|
GDNF family receptor alpha 3
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GHR
|
growth hormone receptor
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIF
|
gastric intrinsic factor (vitamin B synthesis)
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNMT
|
glycine N-methyltransferase
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPD1
|
glycerol-3-phosphate dehydrogenase 1 (soluble)
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2B
|
general transcription factor IIB
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBB
|
hemoglobin, beta
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HEG1
|
heart development protein with EGF-like domains 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNMT
|
histamine N-methyltransferase
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HOXA2
|
homeobox A2
|
|
HOXC8
|
homeobox C8
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGHD
|
immunoglobulin heavy constant delta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33
|
interleukin 33
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
INSRR
|
insulin receptor-related receptor
|
|
IPO5
|
importin 5
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB7
|
integrin, beta 7
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUND
|
jun D proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KANSL1
|
KAT8 regulatory NSL complex subunit 1
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KEL
|
Kell blood group, metallo-endopeptidase
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KIF2C
|
kinesin family member 2C
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIRREL
|
kin of IRRE like (Drosophila)
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LARS
|
leucyl-tRNA synthetase
|
|
LBR
|
lamin B receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEFTY1
|
left-right determination factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LGALSL
|
lectin, galactoside-binding-like
|
|
LGMN
|
legumain
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LOR
|
loricrin
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LSM10
|
LSM10, U7 small nuclear RNA associated
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
|
LUM
|
lumican
|
|
LY96
|
lymphocyte antigen 96
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MANBA
|
mannosidase, beta A, lysosomal
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCH5
|
membrane-associated ring finger (C3HC4) 5
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC3R
|
melanocortin 3 receptor
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM5
|
minichromosome maintenance complex component 5
|
|
MCPH1
|
microcephalin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MED12
|
mediator complex subunit 12
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN1
|
mitofusin 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGP
|
matrix Gla protein
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR126
|
microRNA 126
|
|
MIR146A
|
microRNA 146a
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR221
|
microRNA 221
|
|
MIR27A
|
microRNA 27a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPV17
|
MpV17 mitochondrial inner membrane protein
|
|
MRAP
|
melanocortin 2 receptor accessory protein
|
|
MRC2
|
mannose receptor, C type 2
|
|
MRPS12
|
mitochondrial ribosomal protein S12
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSX1
|
msh homeobox 1
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
NAPRT
|
nicotinate phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NDUFAF4
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 4
|
|
NDUFS4
|
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)
|
|
NEB
|
nebulin
|
|
NELFB
|
negative elongation factor complex member B
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NLGN3
|
neuroligin 3
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPSA
|
novel prostate-specific antigen
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRL
|
neural retina leucine zipper
|
|
NTF4
|
neurotrophin 4
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUCB2
|
nucleobindin 2
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OASL
|
2'-5'-oligoadenylate synthetase-like
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OGN
|
osteoglycin
|
|
ONECUT1
|
one cut homeobox 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX8
|
paired box 8
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
PCDH11Y
|
protocadherin 11 Y-linked
|
|
PCNT
|
pericentrin
|
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDF
|
peptide deformylase (mitochondrial)
|
|
PDPN
|
podoplanin
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
|
PEX1
|
peroxisomal biogenesis factor 1
|
|
PGR
|
progesterone receptor
|
|
PHF8
|
PHD finger protein 8
|
|
PHYKPL
|
5-phosphohydroxy-L-lysine phospho-lyase
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKN3
|
protein kinase N3
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLK4
|
polo-like kinase 4
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PNPLA6
|
patatin-like phospholipase domain containing 6
|
|
POGLUT1
|
protein O-glucosyltransferase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTH
|
parathyroid hormone
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PTX3
|
pentraxin 3, long
|
|
PYY
|
peptide YY
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RB1
|
retinoblastoma 1
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHOA
|
ras homolog family member A
|
|
RHOC
|
ras homolog family member C
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
ROPN1
|
rhophilin associated tail protein 1
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RRBP1
|
ribosome binding protein 1
|
|
RS1
|
retinoschisin 1
|
|
RTN4R
|
reticulon 4 receptor
|
|
RTN4RL2
|
reticulon 4 receptor-like 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100B
|
S100 calcium binding protein B
|
|
SARS2
|
seryl-tRNA synthetase 2, mitochondrial
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCG5
|
secretogranin V
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SEPT10
|
septin 10
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFTPA2
|
surfactant protein A2
|
|
SFTPB
|
surfactant protein B
|
|
SFTPD
|
surfactant protein D
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5
|
|
SIX2
|
SIX homeobox 2
|
|
SKI
|
SKI proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A10
|
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOHLH1
|
spermatogenesis and oogenesis specific basic helix-loop-helix 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SPRR1A
|
small proline-rich protein 1A
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRY
|
sex determining region Y
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
SULF1
|
sulfatase 1
|
|
SULT4A1
|
sulfotransferase family 4A, member 1
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
SYT11
|
synaptotagmin XI
|
|
TBX21
|
T-box 21
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM3
|
transglutaminase 3
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLE3
|
transducin-like enhancer of split 3
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMPO
|
thymopoietin
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPPP
|
tubulin polymerization promoting protein
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRB
|
T cell receptor beta locus
|
|
TRD
|
T cell receptor delta locus
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTK
|
TTK protein kinase
|
|
TTR
|
transthyretin
|
|
TUBB2A
|
tubulin, beta 2A class IIa
|
|
TYMP
|
thymidine phosphorylase
|
|
TYR
|
tyrosinase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UNG
|
uracil-DNA glycosylase
|
|
USP24
|
ubiquitin specific peptidase 24
|
|
USP40
|
ubiquitin specific peptidase 40
|
|
USP6
|
ubiquitin specific peptidase 6
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VSX1
|
visual system homeobox 1
|
|
VSX2
|
visual system homeobox 2
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YTHDC1
|
YTH domain containing 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
